Published in Hematology Week, January 30th, 2012
"This article presents strategies for induction therapy of younger adults and approaches to postremission therapy based on prognostic features. Although some older adults may benefit from intensive chemotherapy and reduced-intensity hematopoietic stem cell transplantation, development of less intensive therapies for older...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
Source: Hematology Week (2012-01-30)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.